SEI Investments’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding MRTX
RI
ACA
EC
BC
AH
SEI Investments's MRTX Position: Q3 2023 in Review
SEI Investments sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q3 2023, closing a stake of 44,302 shares — an estimated $1.6M sold.
SEI Investments first reported a position in MRTX in Q2 2018 and held it in 18 quarters. The position peaked at $3.82M in Q3 2022. 213 funds tracked by Wall St. Rank hold MRTX as of Q3 2023.
- SEI Investments reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- SEI Investments sold 44,302 Mirati Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.6M.
- SEI Investments first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2018 and held it in 18 quarters.
- SEI Investments's Mirati Therapeutics, Inc. Common Stock position peaked at $3.82M in Q3 2022.
- 213 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2023.
Based on SEI Investments's 13F filing for Q3 2023, filed 14 Nov 2023.